USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US?

被引：0
|
作者：
Walshe, Margaret
Borowski, Krzysztof
Kabakchiev, Boyko
Milgrom, Raquel
Stempak, Joanne M.
Steinhart, A. Hillary
Croitoru, Kenneth
Silverberg, Mark S.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1831
引用
收藏
页码：S1142 / S1142
页数：1
相关论文
共 50 条
  • [1] A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease
    Barrau, Mathilde
    Duprat, Manon
    Veyrard, Pauline
    Tournier, Quentin
    Williet, Nicolas
    Marc Phelip, Jean
    Waeckel, Louis
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    Roblin, Xavier
    Paul, Stephane
    JOURNAL OF CROHNS & COLITIS, 2022, : 633 - 643
  • [2] Inflammatory Bowel Disease and Risk of Erectile Dysfunction: What Does the Current Evidence Tell Us?
    Zhao, Shankun
    Wang, Jiamin
    Zhao, Zhigang
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (02): : 357 - 358
  • [3] Inflammatory Bowel Disease and Risk of Erectile Dysfunction: What Does the Current Evidence Tell Us? Response
    Friedman, Sonia
    Norgard, Bente M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (02): : 358 - 359
  • [4] What do eosinophils tell us in biopsies of patients with inflammatory bowel disease?
    Yang, GY
    West, AB
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (02) : 93 - 98
  • [5] Biologics for psoriasis: what does drug survival tell us?
    Veysey, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (02) : 204 - 205
  • [6] Inflammatory bowel disease and genetics: what to tell our patients?
    Peeters, M
    Vermeire, S
    Joossens, S
    Rutgeerts, P
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 24 - 33
  • [7] New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
    Chande, Nilesh
    Marshall, John K.
    Seow, Cynthia H.
    Sandborn, William J.
    Parker, Claire E.
    Nelson, Sigrid
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (12) : 2948 - 2957
  • [8] On the pathogenesis trail: What marker B cell clones tell us about inflammatory bowel disease
    Braun, J
    VallesAyoub, Y
    Berberian, L
    Eggena, M
    Gordon, LK
    Targan, S
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1996, 10 (02): : 115 - 119
  • [9] Methylxanthine use in anaphylaxis: What does the evidence tell us?
    Ernst, ME
    Graber, MA
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) : 1001 - 1004
  • [10] What does hypoalbuminemia tell us in patients with Castleman disease
    Wang, Chen
    LEUKEMIA & LYMPHOMA, 2022, 63 (14) : 3513 - 3513
12345